Panel Discussion: Scaling Clinical Operations to Support Gene Therapies for Larger Populations

• Highlighting the limitations of current small-batch methods in meeting the needs of larger patient populations
• Understanding the unique manufacturing, financial, and regulatory challenges associated with working on common disease indications
• Anticipating the scientific and operational shifts needed to make gene therapy viable for high-prevalence conditions

Speakers: